Evaxion A/S (NASDAQ: EVAX) announced preclinical data for EVX-04, a therapeutic vaccine candidate for acute myeloid leukemia. The company will ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE